Related Experiment Video

Updated: Jun 3, 2026

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

Hutchinson-Gilford progeria is a skeletal dysplasia

Catherine M Gordon1, Leslie B Gordon, Brian D Snyder

  • 1Division of Adolescent Medicine and Endocrinology, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA. catherine.gordon@childrens.harvard.edu

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|March 30, 2011
PubMed

Insights

Children with Hutchinson-Gilford progeria syndrome (HGPS) exhibit unique bone structural abnormalities, not malnutrition. Bone density and geometry are significantly altered, indicating a distinct skeletal dysplasia in this premature aging disorder.

Area of Science:

  • Pediatric Endocrinology
  • Skeletal Dysplasias
  • Genetics of Aging

Background:

  • Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by rapid, premature aging.
  • Skeletal abnormalities, including bone and body composition changes, are key features of HGPS.

Purpose of the Study:

  • To investigate bone density and structural geometry in children with HGPS.
  • To explore relationships between skeletal parameters and anthropometry, body composition, and nutrition in HGPS.

Main Methods:

  • Prospective enrollment of 26 children with HGPS (ages 3.1–16.2 years).
  • Assessment of anthropometry, bone age, dual-energy X-ray absorptiometry (DXA) for areal bone mineral density (aBMD) and body composition.
  • Peripheral quantitative computed tomography (pQCT) for volumetric bone mineral density (vBMD), strength-strain index (SSI), and bone structural geometry.
  • Analysis of serum bone biomarkers, hormonal measures, and nutritional intake.

Main Results:

  • Children with HGPS showed low axial aBMD Z-scores by DXA, which normalized after height age adjustment.
  • Radial vBMD by pQCT showed less striking differences compared to controls.
  • pQCT revealed significant abnormalities in bone structural geometry and skeletal strength at the radius in HGPS patients.
  • Adequate dietary intake confirmed HGPS is not a malnutrition-induced bone loss model.

Conclusions:

  • The skeletal phenotype in HGPS is characterized by distinct abnormalities in bone structure and strength, not solely reduced bone density.
  • These findings suggest HGPS represents a unique skeletal dysplasia rather than a model for malnutrition-related bone loss.

More Related Videos

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

Performing Human Skeletal Muscle Xenografts in Immunodeficient Mice07:48

Performing Human Skeletal Muscle Xenografts in Immunodeficient Mice

Published on: September 16, 2019

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...